TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2012

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 268 56.8 6.1 (44.8 – 68.8) 271 57.1 6.1 (45.1 – 69.1)
Arizona 222 59.2 7.4 (44.7 – 73.7) 229 44.4 10.3 (24.2 – 64.6)
California 316 59.4 4.4 (50.8 – 68.0) 336 57.6 4.4 (49.0 – 66.2)
Connecticut 241 58.0 5.2 (47.8 – 68.2) 249 55.6 5.7 (44.4 – 66.8)
District of Columbia 98 34.9 9.4 (16.5 – 53.3) 106 29.4 8.0 (13.7 – 45.1)
Florida 215 49.9 8.0 (34.2 – 65.6) 230 51.6 7.6 (36.7 – 66.5)
Georgia 142 46.8 7.6 (31.9 – 61.7) 160 45.9 7.0 (32.2 – 59.6)
Hawaii 143 40.2 7.8 (24.9 – 55.5) 152 54.6 6.4 (42.1 – 67.1)
Illinois 205 51.4 6.6 (38.5 – 64.3) 219 45.2 6.7 (32.1 – 58.3)
Indiana 238 46.7 5.9 (35.1 – 58.3) 260 41.3 5.5 (30.5 – 52.1)
Iowa 197 50.1 6.7 (37.0 – 63.2) 201 51.2 6.6 (38.3 – 64.1)
Kansas 388 50.6 4.8 (41.2 – 60.0) 402 50.4 4.7 (41.2 – 59.6)
Louisiana 261 56.0 6.8 (42.7 – 69.3) 274 48.9 6.9 (35.4 – 62.4)
Maine 216 56.1 5.7 (44.9 – 67.3) 228 57.2 5.2 (47.0 – 67.4)
Massachusetts 198 49.0 6.3 (36.7 – 61.3) 232 46.1 5.7 (34.9 – 57.3)
Michigan 448 60.8 4.0 (53.0 – 68.6) 488 60.2 3.9 (52.6 – 67.8)
Mississippi 261 62.5 5.6 (51.5 – 73.5) 261 64.0 5.5 (53.2 – 74.8)
Missouri 227 69.9 6.7 (56.8 – 83.0) 240 63.0 7.0 (49.3 – 76.7)
Montana 277 59.7 5.7 (48.5 – 70.9) 289 57.0 5.8 (45.6 – 68.4)
Nebraska 508 53.7 4.4 (45.1 – 62.3) 523 52.6 4.4 (44.0 – 61.2)
Nevada 142 52.8 8.4 (36.3 – 69.3) 158 49.0 8.0 (33.3 – 64.7)
New Hampshire 264 43.8 5.0 (34.0 – 53.6) 281 44.3 4.7 (35.1 – 53.5)
New Jersey 385 55.4 4.9 (45.8 – 65.0) 409 53.1 4.9 (43.5 – 62.7)
New Mexico 292 60.5 4.9 (50.9 – 70.1) 307 58.5 4.6 (49.5 – 67.5)
New York 173 51.0 7.0 (37.3 – 64.7) 189 45.8 7.7 (30.7 – 60.9)
North Carolina 155 64.9 7.3 (50.6 – 79.2) 174 60.8 7.5 (46.1 – 75.5)
North Dakota 150 53.3 7.2 (39.2 – 67.4) 149 50.1 7.4 (35.6 – 64.6)
Ohio 393 57.0 4.8 (47.6 – 66.4) 416 56.8 5.2 (46.6 – 67.0)
Oklahoma 210 47.0 6.5 (34.3 – 59.7) 216 42.5 6.6 (29.6 – 55.4)
Oregon 198 66.8 5.6 (55.8 – 77.8) 220 61.9 5.5 (51.1 – 72.7)
Pennsylvania 577 57.6 5.0 (47.8 – 67.4) 617 55.1 4.9 (45.5 – 64.7)
Rhode Island 187 61.8 6.0 (50.0 – 73.6) 190 57.0 6.7 (43.9 – 70.1)
Texas 212 59.8 8.2 (43.7 – 75.9) 220 52.8 9.3 (34.6 – 71.0)
Vermont 234 58.4 5.4 (47.8 – 69.0) 244 54.9 5.4 (44.3 – 65.5)
Washington 463 59.8 4.3 (51.4 – 68.2) 487 58.8 4.0 (51.0 – 66.6)
West Virginia 211 44.3 4.5 (35.5 – 53.1) 212 45.8 4.5 (37.0 – 54.6)
Wisconsin 181 55.6 8.2 (39.5 – 71.7) 185 56.6 8.2 (40.5 – 72.7)
37 state total 9,496 55.9 1.5 (53.0 – 58.8) 10,024 53.0 1.5 (50.1 – 55.9)
Median   56.0       53.1    
Range   34.9-69.9       29.4-64.0    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline sample size excludes “DK/Refused”

§ Standard error

Confidence interval